학술논문
ABCL-044 Clinical Outcomes of Commercial CD19-Targeted CAR T-Cell Therapy in Patients With Secondary Central Nervous System Lymphoma
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S355-S355
Subject
Language
ISSN
2152-2650